Details der Publikation - Epstein Barr virus

Epstein Barr virus : methods and protocols

Medienart:	Buch

Erscheinungsjahr:	[2017] © 2017
Erschienen:	New York: Humana Press ; 2017 © 2017

Reihe:	Methods in molecular biology - 1532 Springer protocols

Sprache:	Englisch

Beteiligte Personen:	Minarovits, Janos [HerausgeberIn] Niller, Johann Helmut [HerausgeberIn]

ISBN:	978-1-4939-6653-0 1-4939-6653-7

Nlm:	W1 QW 25
Themen:	Epstein-Barr virus Herpesvirus 4, Human Humans Immunoassay Viral Proteins Virus Cultivation

Umfang:	xiv, 269 Seiten ; Illustrationen

Weitere IDs:	9781493966530

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	875629652

Internformat


LEADER	01000cam a2200265 4500
001	875629652
003	DE-627
005	20230426173946.0
007	tu
008	161222s2016 xxu\|\|\|\|\| 00\| \|\|eng c
016	7		\|a 1108796230 \|2 DE-101
020			\|a 9781493966530 \|c : Book : circa EUR 117.69 (DE) (freier Preis), circa EUR 120.99 (AT) (freier Preis), circa sfr 121.00 (freier Preis) \|9 978-1-4939-6653-0
020			\|a 1493966537 \|9 1-4939-6653-7
024	3		\|a 9781493966530
028	5	2	\|a 978-1-4939-6653-0
028	5	2	\|a 86378842
035			\|a (DE-627)875629652
035			\|a (DE-599)DNB1108796230
040			\|a DE-627 \|b ger \|c DE-627 \|e rda
041			\|a eng
044			\|c XD-US
050		0	\|a QR400.2.E68
060		0	\|a W1
060		0	\|a QW 25
082	0		\|a 616.99/446 \|2 23
082	0	4	\|a 610 \|q DE-101
245	1	0	\|a Epstein Barr virus \|b methods and protocols
264		1	\|a New York \|b Humana Press \|c [2017]
264		4	\|c © 2017
300			\|a xiv, 269 Seiten \|b Illustrationen
336			\|a Text \|b txt \|2 rdacontent
337			\|a ohne Hilfsmittel zu benutzen \|b n \|2 rdamedia
338			\|a Band \|b nc \|2 rdacarrier
490	1		\|a Methods in molecular biology \|v 1532
490	0		\|a Springer protocols
505	8	0	\|t Current trends and alternative scenarios in EBV research \|r Janos Minarovits and Hans Helmut Niller
505	8	0	\|t Epstein-Barr virus : clinical ciagnostics \|r Hans-Helmut Niller and Georg Bauer
505	8	0	\|t Establishment of EBV-infected lymphoblastoid cell lines \|r Noemi Nagy
505	8	0	\|t Generation and infection of organotypic cultures with Epstein-Barr virus \|r Rachel M. Temple, Craig Meyers, and Clare E. Sample
505	8	0	\|t Affinity purification-mass spectroscopy methods for identifying Epstein-Barr virus-host interactions \|r Anna A. Georges and Lori Frappier
505	8	0	\|t Use of 3D telomere FISH for the characterization of the nuclear architecture in EBV-positive hodgkin's lymphoma \|r Hans Knecht and Sabine Mai
505	8	0	\|t Analysis of EBV transcription using high-throughput RNA sequencing \|r Tina O'Grady, Melody Baddoo, and Erik K. Flemington
505	8	0	\|t Analysis of viral promoter usage in EBV-infected cell lines : a comparison of qPCR following conventional RNA isolation and nuclear run-on assay \|r Kalman Szenthe and Ferenc Banati
505	8	0	\|t Analysis of viral and cellular microRNAs in EBV-infected cells \|r Rebecca L. Skalsky
505	8	0	\|t Isolation and characterization of exosomes released by EBV-immortalized cells \|r Gulfaraz Khan and Waqar Ahmed
505	8	0	\|t Functional analysis of exosomes derived from EBV-infected cells \|r Gulfaraz Khan and Pretty S. Philip
505	8	0	\|t Terminal repeat analysis of EBV genomes \|r Ferenc Bánáti, Anita Koroknai, and Kálmán Szenthe
505	8	0	\|t Characterization of EBV promoters and coding regions by sequencing PCR-amplified DNA fragments \|r Kalman Szenthe and Ferenc Bánáti
505	8	0	\|t Use of chromatin precipitation coupled to DNA sequencing (ChIP-Seq) for the analysis of Zta binding to the human and EBV genome \|r Anja Godfrey, Sharada Ramasubramanyan, and Alison J. Sinclair
505	8	0	\|t Analysis of viral epigenotypes using bisulfite sequencing : a detailed protocol for the crucial bisulfite modification and PCR amplification steps \|r Daniel Salamon
505	8	0	\|t Analysis of viral epigenotypes using chromatin immunoprecipitation \|r Ferenc Bánáti and Kálmán Szenthe
505	8	0	\|t Mice with reconstituted human immune system components as a tool to study immune cell interactions in EBV infection \|r Frank Heuts and Noemi Nagy
505	8	0	\|t Generation and analysis of humanized mouse model of EBV infection \|r Ken-Ichi Imadome and Shigeyoshi Fujiwara
505	8	0	\|t EBV-directed T cell therapeutics for EBV-associated lymphomas \|r Lauren P. McLaughlin, Stephen Gottschalk, Cliona M. Rooney, and Catherine M. Bollard.
650		0	\|a Epstein-Barr virus \|v Laboratory manuals
650		2	\|a Humans
650		2	\|a Herpesvirus 4, Human \|x physiology
650		2	\|a Herpesvirus 4, Human \|x isolation & purification
650		2	\|a Immunoassay \|x methods
650		2	\|a Viral Proteins \|x chemistry
650		2	\|a Viral Proteins \|x genetics
650		2	\|a Virus Cultivation \|x methods
700	1		\|a Minarovits, Janos \|e herausgeberin \|4 edt
700	1		\|a Niller, Johann Helmut \|e herausgeberin \|4 edt
710	2		\|a Springer Science + Business Media LLC \|e Verlag \|0 (DE-588)1065492340 \|0 (DE-627)816192375 \|0 (DE-576)425241297 \|4 pbl
776	1		\|z 9781493966554
830		0	\|a Methods in molecular biology \|v 1532 \|9 1532 \|w (DE-627)131029002 \|w (DE-576)010864504 \|w (DE-600)1095346-2 \|x 1064-3745 \|7 ns
912			\|a GBV_ILN_55
912			\|a ISIL_DE-Goe116
912			\|a SYSFLAG_1
912			\|a GBV_KXP
912			\|a SSG-OLC-PHA
951			\|a BO
953			\|2 045F \|a 616.99/446
980			\|2 55 \|1 01 \|x 3055 \|b 1654677787 \|c 00 \|f --%%-- \|d E 4/07 \|e --%%-- \|j --%%-- \|y z \|z 22-12-16

Epstein Barr virus : methods and protocols

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände